Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-83.68	26.30	161.14
Graham Fair Price	46.57	29.29	19.98
PEG	-83.53	-0.04	0.27
Price/Book	-14.82	0.84	0.98
Price/Cash Flow	67.94	-14.03	-43.77
Prices/Earnings	-59.60	13.70	-33.92
Price/Sales	-14.59	2.24	2.62
Price/FCF	67.94	-14.03	-43.77
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	12.40	0.08	0.07
Operating Margin	-2.81	0.05	-0.06
ROA	113.78	< 0.005	< 0.005
ROE	< 0.005	0.02	110.85
ROIC	< 0.005	0.01	64.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-75.94
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.83	1.98	8.11
EPS QOQ	-1.27	3.11	145.23
FCF QOQ	-2.07	-1.69	18.33
Revenue QOQ	-0.06	0.01	-82.86
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	49.73	50.33	1.21
Days Sales Outstanding (DSO)	33.62	36.99	10.02
Inventory Turnover	1.81	1.79	-1.19
Debt/Capitalization	0.28	0.28	-1.92
Quick Ratio	1.14	1.05	-7.80
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	49.51	49.97	0.94
Cash	13.30	9.95	-25.16
Capex	-2.85	-2.86	-0.04
Free Cash Flow	-1.11	-2.98	-168.19
Revenue	18.57	18.70	0.67
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.76	1.71	-2.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	18.30	4.84	-73.53
Naive Interpretation	Member

06 - Financial Health · Weak

Rating